Report copyright - 2019 Coronary Artery Disease Program Evaluation · (91.03%) received monitoring for ACE Inhibitors or ARBs, 9,726 (90.85%) received monitoring for Diuretics with a total of 22,862
Please pass captcha verification before submit form